Tag: corporation

[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Therapeutic Apheresis Market size & share revenue was valued at approximately USD 3.84 Billion in 2025 and is expected to reach USD 4.18 Billion in 2026 and is expected to reach around USD 8.94 Billion by 2035, at a CAGR of 7.9% between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Terumo BCT Inc., Fresenius Kabi AG, Haemonetics Corporation, B. Braun Melsungen AG, Asahi Kasei Medical Co. Ltd., Miltenyi Biotec GmbH, Nikkiso Co. Ltd., Kaneka Corporation, Mallinckrodt Pharmaceuticals (Uvadex/ECP), Photomedex Inc., Macopharma SAS and others.

TORONTO, June 24, 2026 (GLOBE NEWSWIRE) -- (TSX: IMP; OTCQB: ITMSF) – Intermap Technologies Corporation (“Intermap” or the “Company”) held its annual general meeting of shareholders (the “Meeting”) on June 24, 2026, at the TMX Market Centre, Bourse Room, located at 120 Adelaide St W, Toronto, Ontario. A total of 22,993,978 Class A common shares of Intermap (“Common Shares”), representing 31.16% of the total Common Shares outstanding, were represented in person or by proxy at the Meeting.

BROOKFIELD, News, June 24, 2026 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Corporation (the “Corporation”) (TSX, NYSE: BIPC) today announced that all nine nominees proposed for election to the board of directors by holders of class A exchangeable subordinate voting shares (“Exchangeable Shares”) and holders of class B multiple voting shares (“Class B Shares”) were elected at the Corporation’s annual meeting of shareholders held on June 24, 2026 in a virtual meeting format. Detailed results of the vote for the election of directors are set out below.

NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Prospect Floating Rate and Alternative Income Fund, Inc. (“Prospect Floating Rate and Alternative Income Fund” or the “Fund”), announced today that the Fund’s Board of Directors has declared the monthly “base” cash common shareholder distribution and its quarterly cash “bonus” common shareholder distribution for June 2026.